Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Riedl

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
NPJ Precision Oncology|April 22, 2025
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapiesMarwa Abdel Hamid, Lorenz M Pammer, Silvia Oberparleiter, et al.
Elife|July 13, 2016
Complementary shifts in photoreceptor spectral tuning unlock the full adaptive potential of ultraviolet vision in birdsMatthew B Toomey, Olle Lind, Rikard Frederiksen, et al.
Scientific Reports|July 10, 2020
Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapyMarie-Christin Klöckl, Anne-Katrin Kasparek, Jakob M Riedl, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Clinical and Experimental Immunology|April 23, 2014
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trialA Malbrán, M Riedl, B Ritchie, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2018
Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methodsMaria A Smolle, Veroniek M van Praag, Florian Posch, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
NPJ Precision Oncology|April 22, 2025
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapiesMarwa Abdel Hamid, Lorenz M Pammer, Silvia Oberparleiter, et al.
Elife|July 13, 2016
Complementary shifts in photoreceptor spectral tuning unlock the full adaptive potential of ultraviolet vision in birdsMatthew B Toomey, Olle Lind, Rikard Frederiksen, et al.
Scientific Reports|July 10, 2020
Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapyMarie-Christin Klöckl, Anne-Katrin Kasparek, Jakob M Riedl, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Clinical and Experimental Immunology|April 23, 2014
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trialA Malbrán, M Riedl, B Ritchie, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2018
Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methodsMaria A Smolle, Veroniek M van Praag, Florian Posch, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Pageof 21